About 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine
6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine (PubChem CID 157104194) has the molecular formula C79H103Cl5N20O5S
and a molecular weight of 1622.16 g/mol. Its IUPAC name is 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine.
Frequently Asked Questions
What is the IUPAC name of 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine?
The IUPAC name of 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine (CID 157104194) is 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine.
What is the SMILES notation for 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine?
The canonical SMILES for 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine is CC(=O)N(C)C1CCN(c2cc(Cl)cc3[nH]ncc23)CC1(C)C.CC(=O)N1CCC2(CC1)CN(c1cc(Cl)cc3[nH]ncc13)C2.CN(C1CCN(c2cc(Cl)cc3[nH]ncc23)CC1(C)C)S(C)(=O)=O.Clc1cc(N2CCC(N3CCOCC3)CC2)c2cn[nH]c2c1.Clc1cc(N2C[C@H]3CC[C@@H](C2)NC3)c2cn[nH]c2c1.
What is the InChIKey of 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine?
The InChIKey is AGCPZUNXLRLGAF-QILOTKQNSA-N. The full InChI is InChI=1S/C17H23ClN4O.C16H23ClN4O2S.C16H19ClN4O.C16H21ClN4O.C14H17ClN4/c1-11(23)21(4)16-5-6-22(10-17(16,2)3)15-8-12(18)7-14-13(15)9-19-20-14;1-16(2)10-21(6-5-15(16)20(3)24(4,22)23)14-8-11(17)7-13-12(14)9-18-19-13;1-11(22)20-4-2-16(3-5-20)9-21(10-16)15-7-12(17)6-14-13(15)8-18-19-14;17-12-9-15-14(11-18-19-15)16(10-12)21-3-1-13(2-4-21)20-5-7-22-8-6-20;15-10-3-13-12(6-17-18-13)14(4-10)19-7-9-1-2-11(8-19)16-5-9/h7-9,16H,5-6,10H2,1-4H3,(H,19,20);7-9,15H,5-6,10H2,1-4H3,(H,18,19);6-8H,2-5,9-10H2,1H3,(H,18,19);9-11,13H,1-8H2,(H,18,19);3-4,6,9,11,16H,1-2,5,7-8H2,(H,17,18)/t;;;;9-,11-/m....0/s1.
What are the key properties of 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine?
6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine has a molecular weight of 1622.16 g/mol, XLogP of 13.60, 9 rotatable bonds, 6 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 6-chloro-4-[(1S,5S)-3,6-diazabicyclo[3.2.2]nonan-3-yl]-1H-indazole;1-[2-(6-chloro-1H-indazol-4-yl)-2,7-diazaspiro[3.5]nonan-7-yl]ethanone;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylacetamide;N-[1-(6-chloro-1H-indazol-4-yl)-3,3-dimethylpiperidin-4-yl]-N-methylmethanesulfonamide;4-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]morpholine is sourced from PubChem (CID 157104194), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).